Core Insights - Co-Diagnostics, Inc. has developed a proprietary sample preparation instrument aimed at enhancing decentralized PCR testing for tuberculosis (TB) in nearly 30,000 primary health centers across India [1][3][6] - The new instrument is designed to be low-cost and user-friendly, facilitating sample processing in resource-limited settings, and will support both sputum and novel tongue swab sample collection [2][3] Company Developments - The instrument features single-button operation, eliminating the need for measurement or dispensing tools, which allows for rapid sample preparation with minimal training [2][3] - The CEO of Co-Diagnostics emphasized that the new device addresses the challenges of sample preparation for PCR testing, which has historically been costly and time-consuming when performed in centralized labs [3] Market Impact - The introduction of this instrument is seen as a significant transition in the TB testing landscape in India, potentially decentralizing PCR testing from approximately 1,000 district hospitals to primary health centers [3][6] - The company aims to maintain high standards for performance, cost-efficiency, safety, and ease-of-use while keeping production costs low and strengthening partnerships in India [3][6] Future Opportunities - The new device is expected to pave the way for affordable preparation of other sample types at the point-of-care, creating opportunities to expand into blood-borne pathogens [3][6] - Systronics, a subsidiary of Ambalal Sarabhai Enterprises Limited, is anticipated to be the manufacturing partner for the instrument, which will qualify for benefits under the "Make in India" initiative [3][6]